Organisation
Statens Serum Institut (SSI) consists of a management board, four health priority areas and staff units – all with their own departments.
See the organisation chart as a pdf.
Management board
Henrik Ullum (CEO)
Ole Jensen (Executive Vice President)
Helle Birk Krogsgaard (Chief Financial Officer)
Anne-Marie Vangsted (TestCenter Danmark)
Tyra Grove Krause (Executive Vice President ad interim)
Organisation
Corporate Affairs
Center for Biosecurity & Biopreparedness
Business Support & Campus (Helle Birk Krogsgaard, Chief Financial Officer)
Finance
Campus
Supply
Business Development
QA & Compliance
Infectious Disease Preparedness (Tyra Grove Krause, Executive Vice President ad interim)
Infectious Disease Preparedness
Infectious Disease Epidemiology & Prevention
Bacteria, Parasites & Fungi
Virus & Microbiological Special Diagnostics
International Reference Laboratory of Mycobacteriology
Prediagnostics & Service
Biobank & Biomarkers (David Hougaard, Executive Vice President ad interim)
Biobank & Biomarkers
Congenital Disorders
Danish National Biobank
Research - vaccines (Peter L. Andersen, Research Director)
Infectious Disease Immunology
Vaccine Development
Research - epidemiology (N.N., Executive Vice President)